Immune thrombocytopenia

Researchers in Turkey have uncovered changes in immune cells and surface proteins on platelets, which are tiny, colorless cell fragments in the blood that help…

Platelets in active immune thrombocytopenia (ITP) have unique changes in genetic activity that make them more activated than platelets from healthy people or from…

An elderly man initially thought to have primary immune thrombocytopenia (ITP), which occurs without an identifiable underlying cause, was later found to have a…

Regulatory authorities in Japan have approved Sanofi’s oral therapy Wayrilz (rilzabrutinib) for treating people with immune thrombocytopenia (ITP) who haven’t responded to,…

A donor stem cell transplant and follow-up treatments helped a teenage girl achieve long-term remission from refractory immune thrombocytopenia (ITP), according to a case…

Symptoms unrelated to bleeding, such as fatigue and mental health struggles, are common among people with immune thrombocytopenia (ITP) — but the impact of…

A mutation in the gene ELF4 likely set the stage for a teenage boy to develop immune thrombocytopenia (ITP), according to a new report. The…

Treatment with all-trans retinoic acid (ATRA), a compound derived from vitamin A, may help restore production of clot-promoting platelets in people with immune thrombocytopenia…

Blocking the activity of an enzyme known as MELK may help boost the production of platelets — tiny cell fragments that improve blood clotting and…

Regulatory authorities in Brazil have approved the oral therapy Tavalisse (fostamatinib disodium hexahydrate) for adults with chronic …